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Abstract
The enzymatic activity of Helicobacter pylori’s urease neutralises stomach acidity, thereby promoting infection by this
pathogen. Urease protein has also been found to interact with host cells in vitro, although this property’s possible
functional importance has not been studied in vivo. To test for a role of the urease surface in the host/pathogen
interaction, surface exposed loops that display high thermal mobility were targeted for inframe insertion mutagenesis. H.
pylori expressing urease with insertions at four of eight sites tested retained urease activity, which in three cases was at
least as stable as was wild-type urease at pH 3. Bacteria expressing one of these four mutant ureases, however, failed to
colonise mice for even two weeks, and a second had reduced bacterial titres after longer term (3 to 6 months)
colonisation. These results indicate that a discrete surface of the urease complex is important for H. pylori persistence
during gastric colonisation. We propose that this surface interacts directly with host components important for the host-
pathogen interaction, immune modulation or other actions that underlie H. pylori persistence in its special gastric mucosal
niche.
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Introduction
H. pylori chronically infects the gastric mucosa of billions of
people worldwide, causes peptic ulcer disease in 10% or more of
them, and is also implicated as an early critical risk factor for
gastric cancer, one of the most frequently lethal malignancies in
human populations [1]. One of the first characterised factors
essential for colonisation by H. pylori was urease, an abundant
enzyme that decreases the acidity of H. pylori’s immediate
environment by generating ammonia and carbonate from the
urea we secrete as metabolic waste [2,3]. Although such local
control of gastric acidity is considered essential, urease-negative
H. pylori strains were unable to colonise piglets whose acid
secretion had been suppressed, suggesting an additional role for
urease [4]. Possible explanations include use of ammonia that
urease generates to synthesise essential metabolites, especially
amino acids [5]; protection from peroxynitrite [6], enhanced
survival in macrophages [7]; evasion of phagocytosis [8] and
complement mediated opsonisation [9]. Quite a different
explanation invokes urease-host tissue interactions, independent
of enzymatic activity, and is based on in vitro studies that detected
urease activation of macrophages [10], monocytes [11], blood
platelets [11], dysregulation of gastric epithelial tight junctions
[12] and induction of cytokine production from gastric epithelial
cells [13] through binding to CD74 (MHC class II invariant
chain) [14]. H. pylori urease consists of a dodecamer of UreA-
UreB subunits (26.5 and 61.7 kDa, respectively), assembled as
four alpha/beta trimers, producing a ball-like supramolecular
structure [15,16]. We propose that properties of the dodecamer
surface contribute to urease’s acid stability [15] and host
interactions. We tested the role of the urease surface in H.
pylori/host interactions, and found that surface regions of this
enzyme in which changes that did not affect enzymatic activity
impaired bacterial persistence in a murine experimental infection
model.
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Urease Altered on the Surface can Retain De-acidification
Function
To test the possible involvement of the urease surface in host-
pathogen interaction, we generated H. pylori with inframe insertions
at eight sites in urease. First the UreA/UreB structure [15] was
analysed in silico to identify surface regions that might tolerate the
insertion of two epitope tags (Figure 1a). Mutant H. pylori with in
frame insertions of DNA encoding epitope tag sequences at eight
specific sites in chromosomal ureA and ureB genes were then
generated by a PCR and transformation method. The sites chosen
were those corresponding to the N and C-termini of UreA and
UreB, respectively and six additional regions in which structural
considerations suggested that modest sequence changes would not
necessarily inactivate urease’s enzymatic activity. To reduce
structural stresses resulting from epitope tag insertion the tags were
separated from retained urease sequences by a flexible amino acid
linker. The tagged region was also flanked by semi-random six
amino acid linkers whose underlying DNAs had been designed to
exclude two of the three translation termination codons.
Four of eight candidate sites yielded mutant urease enzymes
that allowed H. pylori to hydrolyse urea (Figure 1b; Figure 1c).
Insertions at the other four sites did not result in isolation of
bacteria expressing functional ureases under these conditions.
Western blot analysis confirmed that H. pylori producing mutant
urease at sites 1, 3, 4 or 8 contained insertions of epitope tags
(Figure 2a). The pH of the mouse stomach lumen, which H. pylori
must traverse to establish gastric mucosal infection, is between 3
and 4 [17]. To determine if these insertions in urease’s surface
exposed loops altered its activity or stability we assayed enzymatic
activity in bacteria expressing wild-type or mutant urease after
exposure to acid (pH 3). One of the mutant ureases (insertion at
site 1) was more sensitive than wild type, and the three other
mutant ureases were similar to wild type in their sensitivity to this
acid treatment (Figure 2b; Student’s T-test; p,0.05).
Altering Surface Properties of Urease Alters Persistence in
the Host
The ability of each mutant urease-producing H. pylori strain to
colonise C57BL/6 mice was tested. The strain with site 3-mutant
urease did not colonise mice (data not shown) and was not studied
Figure 1. Recombinant regions of urease and selection for enzyme function. a) Molecular structure of urease showing insertion sites on the
surface of urease. Urease subunit A (green) and subunit B (blue) associate to form a dodecameric supramolecular molecule [15,16]. Sites 1 to 8
correspond to residues 102, 231 and 238 from UreA and residues 1, 66, 326, 541 and 549 from UreB, respectively. Insertion sites 1, 3, 4, and 8 are
indicated in red. Urease activity could not be retained when altered at sites 2, 5, 6, and 7 (pink). b) Selection of bacteria producing functional urease
on acidified media supplemented with the urease substrate, urea. Left side: X47 wild type; the colour change observed on the left side indicated that
bacterial colonies were producing functional urease and growing. Right side: X47 DureA: there was no colour (X47 wild-type). Colour change did not
occur on the right side, indicating that inoculated colonies were unable to grow or functional urease was not being produced (X47 DureA). c)A
schematic showing insertion sites at the urease locus of DNA coding epitopes and linkers. Insertions were made in DNA corresponding to insertion
after amino positions 102 (site 1) and 238 (site 3) of UreA (GenBank AAD07144.1), and amino acid positions 1 (site 4) and 549 (site 8) of UreB (GenBank
AAD07143.1). Insertions at sites 3 and 4 correspond to the C- and N-termini of UreA and UreB, respectively. DNA coded HA(T): hemagglutinin T cell
eptitope; HA(B) hemagglutinin B cell epitope; SR linker: semi-random linker; linker: GPSL linker; FLAG: FLAG epitope; STOP: STOP codon.
doi:10.1371/journal.pone.0015042.g001
Urease Surface and Helicobacter pylori Persistence
PLoS ONE | www.plosone.org 2 November 2010 | Volume 5 | Issue 11 | e15042further, whereas each of the other three mutant strains colonised
mice as efficiently as the wild-type in short-term (,3 months)
infections. However, persistence of H. pylori with site 8-mutant
urease was greatly reduced over longer periods of time (Figure 3a).
In confirmation, bacterial titres in mouse stomachs and anti-H.
pylori IgG in serum were each much reduced relative to wild type
and the other two mutants in the case of ten month infection by
this strain (Figure 3b, c). We note that H. pylori expressing urease
containing the recombinant at site 8 insertion, which was present
in infected animals at 3 months of infection at bacterial load
similar to that of bacteria expressing wild type urease (Figure 3a),
exhibited a weaker humoral response against the urease B subunit
(UreB) than did the wild type strain, but a normal response against
total H. pylori antigen (Figure 3d). Important in our infection
protocol, each inoculation used a pool of three independent
transformant clones. This rules out concerns of possible bacterial
attenuation by secondary chromosomal mutations distinct from
the insertions within urease. Further tests showed that nearly all H.
pylori recovered from mice 10 months after inoculation still
expressed the expected mutant urease, which showed that this
persistent colonisation was not due to loss of inserted DNAs. As the
sole exception, just one mouse initially infected with the site 1
mutant strain seemed to produce revertant urease at ten months
(Figure 4). It was also striking that reduced urease activity
measured in vitro did not correlate well with reduced colonisation
ability. For example, the site 1 mutant strain, whose urease was
less acid stable than the others, colonised mice as well as wild-type,
and the site 8 mutant, whose urease activity was similar in acid
resistance to that of wild type, was nevertheless less persistent in
mouse colonisation. Rather, we propose an alternative role for the
urease surface around site 8 (Figure 1a), important during chronic
infection.
Discussion
In summary, a structure-based insertion mutagenesis of the
urease complex identified two discrete regions on the enzyme
surface that are needed for colonisation or persistence of H. pylori,
site 3 and site 8 (Figure 1a). The inability of mutant H. pylori to
colonise mice due to an insertion at site 3 gives further support for
an alternative role of urease, different from acid neutralisation and
warrants further investigation. In addition, our results suggest that
the site 8 region is not essential for the de-acidification function of
urease, but rather is involved in an alternative function required for
persistence of infection in the host. Site 8 is located in the turn of a
beta-meander of the urease complex surface. No insertions or
deletions are found at this site in homologous urease sequences in
diverse organisms (Figure S1) and we therefore propose that the
precise structure of this beta-meander is important for urease’s
alternative role duringlong-term colonisation. Sites 3 and -8havein
common the feature that both are located in proximity to the
rotation axis that connects three alpha/beta trimers. Since
enzymatic activity relies on the integrity of the alpha/beta trimer,
the insertion of tags at sites 3 and -8 could modify the trimer/trimer
interaction surface without compromising the enzymatic activity.
Adaptive immune responses change dramatically during the
establishment and maintenance of chronic H. pylori infection, in
particular at the site of infection. Urease site 8 overlaps with an
established H. pylori CD4
+ T-cell epitope, in response to which
splenic lymphocytes produce cytokine IL-4 [18], a promoter of Th2
responses and driver of antibody production. In contrast the
sequences at sites 1, 3 and 4 do not coincide with any known B or
T cell epitopes. Since urease constitutes up to 10% of bacterial
protein [2,3] the removal of an abundant Th2 driver may prevent
adequate immune modulation by H. pylori important for persistence
and thereby facilitate bacterial clearance by further increasing the
Th1 bias during H. pylori infection. The observations that H. pylori
interferes with dendritic cells [19] and that CD74 plays a role in
regulation of the motility of dendritic cells [20] are in line with a role
of urease in the modulation of the immune response to achieve
persistence. This hypothesis is further supported by the observation
that endogenous CD74 receptor ligands or ligands from human
pathogens function as trimers [21,22] and an inference that
insertions of tags at sites 3 and -8 could affect the trimerisation of
urease alpha/beta trimers. Alternatively, given that binding of H.
pylori urease to CD74 on the gastric epithelium increases IL-8
secretion and up regulation of inflammatory cytokines [23] we can
imagine that modification of the urease site 8 region interferes with a
Figure 2. Recombinant urease activity and acid stability. a)
Western Blot analysis of H. pylori producing urease with insertions at
sites 1, 3, 4 or 8. Lanes 1: Maker (MW: KDa shown); Lane 2: X47 (site 1);
Lane 3: X47 (site 3); Lane 4: X47 (site 4); Lane 5: X47 (site 8). Mutant
urease was detected using anti-FLAG antibody, directed against UreA
(lanes 2 and 3) or UreB (lanes 4 and 5) mutants. b) Ability of
permeabilised bacteria expressing wild-type or mutant urease to
neutralise acid after incubation at pH 3 in the presence of urea. To
determine acid stability and activity of wild-type and mutant ureases,
bacteria were incubated at pH 3 for 0, 2 or 10 min prior to assay of
urease activity. After pre-incubation the solution pH was adjusted to
pH 7, neutralised, urea was added as substrate and urease activity was
measured by a change in pH, as indicated by a change in the colour of
phenol red. Significantly reduced urease activities independent of pre-
incubation at pH 3 are annotated ‘‘ * ’’ (Student’s T-test, 2 tailed, equal
variance). SEM displayed (n=3).
doi:10.1371/journal.pone.0015042.g002
Urease Surface and Helicobacter pylori Persistence
PLoS ONE | www.plosone.org 3 November 2010 | Volume 5 | Issue 11 | e15042direct interaction with CD74-type host cell receptors, and reduces
the pro-inflammatory response (which contributes to tissue damage,
and thereby release of metabolites on which H. pylori is thought to
feed)and therebypreventschronicinfection.The modification of the
site 8 epitope in the recombinant urease also might interfere with
urease’s chemotactic activity abrogating the inflammatory cell
response. This scenario is compatible with the penetration of urease
into the lamina propria where it is in close proximity to phagocytic
cells [24] and with the marked mucosal infiltration by polymorpho-
nuclear leukocytes, macrophages and lymphocytes during H. pylori
infection and resultant characteristic persistent gastritis. Further
studies examining the role of the urease surface in these interactions
are required to identify precisely what is the target receptor of the
urease surface at site 8 region and to elucidate the mechanism
underlying the urease surface-mediated H. pylori persistence.
Conclusions
In conclusion, the urease complex is multifunctional. The
surface properties of this protein, distinct from the ureolytic
activity per se, were found to be important for H. pylori colonisation
and persistence. We hypothesise that the modification of the
urease surface at site 8 compromises CD74-mediated immune
modulation, reduces the pro-inflammatory response elicited by the
epithelial cells or increases the Th1 bias via the dendritic cells.
Alternatively, other receptors, or yet unidentified mechanisms,
might be involved in the urease surface-mediated H. pylori
persistence. Figure 5 presents one appealing view of the multiple
roles attributed to the urease complex, including urea hydrolysis,
opsonisation, platelet aggregation, survival in macrophages,
chemotaxis and immune modulation through CD74. Given the
many failed efforts to develop anti-H. pylori vaccines to date, a
better molecular understanding of factors important in persistence
should contribute to development of new, much needed
therapeutic approaches.
Materials and Methods
Bacterial Strains and Growth Conditions
Streptomycin resistant H. pylori strain X47 was used for all
experiments [25]. Bacteria were grown on Brain Heart Infusion
(BHI) based agar plates supplemented with 5% horse blood and
when appropriate, with erythromycin (10 mg/mL) or streptomycin
(10 mg/mL) in an atmosphere containing 5% CO2. H. pylori
producing functional urease were selected on BHI based agar
plates supplemented with 7% (v/v) horse serum. Phenol, red
(100 mg/L), and urea (600 mg/L) were added, and the molten
agar was acidified to pH 5 using 1M HCl when needed to select
for H. pylori producing functional urease, as illustrated in Fig. 2.
DNA containing the rpsL,ermB (selectable and contraselectable
cassettes [26]) flanked by segments of urease gene DNA (for
homologous recombination), at the urease locus, were produced
using splicing by overlap extension PCR [27] and inserted at the
Figure 3. Insertion mutant but active urease can affect bacterial colonisation. a) Persistence over 15 months expressed as percentage of
colonised mice at each time point (n=5–15). b) Colonisation level of mice infected with H. pylori expressing mutant urease after 15 months (n=5;
median displayed). c) Persistence of H. pylori expressing mutant urease as indicated by anti-H. pylori IgG levels (n=12–20; median displayed). Strains
were recombinant at either sites 1, 4 or 8 in urease. d) Comparison of anti-H. pylori IgG and anti-UreB IgG levels resulting from colonisation of mice for
3 months with X47 expressing wild-type urease, X47 (wt), or urease mutant at site 8, X47 (site8), (n=10–20; median displayed).
doi:10.1371/journal.pone.0015042.g003
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derivative of H. pylori strain X47 [25] using natural transformation
and homologous recombination. DNA encoding HA epitopes (aa
150–159 and 110–120 of Influenza virus A/PR/8/34 hemagglu-
tinin protein [28]), flexible linkers (described below) and a FLAG
tag were similarly fused to regions of DNA for homologous
recombination and transferred to modified H. pylori, replacing the
rpsL.ermB counter selection cassette.
Structural Biology
In order to predict sites in urease which were tolerant to epitope
insertion, the three-dimensional structure of the H. pylori urease
complex was reconstructed from deposited coordinates (PDB-id:
1e9y) by applying the crystallographic symmetry operators. The
urease complex, consisting of 12 UreA and 12 UreB polypeptide
chains, was visually inspected for surface exposed loops showing
high thermal mobility likely to tolerate insertions of epitope tags.
The average temperature factors for main chain atoms of sites 1 to
8 where 64.3 A ˚ 2, 70.0 A ˚ 2, 36.6 A ˚ 2, 52.9 A ˚ 2, 23.3 A ˚ 2, 105.0 A ˚ 2,
59.6 A ˚ 2, and 61.8 A ˚ 2 whereas the average temperature factors for
main chain atoms of UreA and UreB where 43.8 A ˚ 2 and 34.9 A ˚ 2,
respectively.
Splicing by Overlap Extension (SOE) PCR
All PCR constructions used 26695 genomic DNA as template
for initial amplifications. Primers used in this study are shown in
Table S1 and the combinations used are shown in Table S2. The
principles of splicing by overlap PCR have been previously
reported [27]. To construct rpsL,ermB cassette [29] flanked by
regions for homologous recombination 3 stages of PCR were
performed. Stage 1 involved the amplification of the rpsL,ermB
cassette, and flanking regions for homologous recombination at
the urease locus. Stage 2 involved the addition of either flanking
region to the rpsL,ermB cassette using 2 way SOE PCR, Stage 3
involved using these products as template to add both flanking
regions to the rpsL,ermB cassette using 2 way SOE PCR (Table S2).
To produce DNA encoding HA (aa 150–159 and aa 110–120 of
Influenza virus A/PR/8/34 hemagglutinin protein; [28]) and
FLAG (DYKDDDDK) epitopes separated by a four amino acid
linker, flanked by semi-random six amino acid linkers and regions
for homologous recombination, 3 stages of PCR were performed
using AccuPrime
TM Pfx Supermix (Invitrogen). Stage 1 involved
the addition of flanking linkers, stage 2 involved the addition of
HA and FLAG epitopes, stage 3 involved the addition of flanking
regions for homologous recombination using 2-way SOE PCR
(Table S2). Thermocycling conditions were as follows: 94uC for
15 s, 56uC for 20 s, 68uC for 3.5 min (10 cycles). After the
addition of primers an additional 35 cycles of 94uC for 15 s, 62uC
for 20 s, 68uC for 3.5 min were performed, followed by a final
extension of 3 min. Extension times were varied according to PCR
product lengths.
Natural Transformation of H. pylori
Overnight cultures of H. pylori X47 DureAB rpsL.erm grown on
BHI based agar plates were subcultured onto plates supplement-
ed with DENT (Oxoid) in lawns of approximately 2 cm in
diameter. PCR products were DpnI treated to remove residual
genomic DNA and purified QIAQuick PCR Purification Kit
(Quiagen) prior to use in transformation. Transformation was
performed by the addition of approximately 1 mg of purified
PCR product after growth of bacterial lawns for 6–8 hrs. After
overnight incubation putative transformants were streaked on
selective media. Bacteria harbouring functional urease contain-
ing permissive linkers were selected from pools of transformant
bacteria by streaking on acidified media supplemented with the
urease substrate, urea.
Experimental Infection of Mice
C57BL/6, Helicobacter free, mice were purchased from the
Animal ResourceCentre(Perth, WesternAustralia). Studieswere
performed with approval from the UWA Animal Ethic
Committee (approval no. 07/100/598). Eight week old mice
were orogastrically inoculated with approximately 1.0610
9 H.
pylori harvested from an overnight agar plate based culture into
BHI broth (Oxoid). Mice were inoculated with pools of 3
independent, genetically characterised clones expressing wild
type or mutant urease. To determine the level of colonisation,
stomachs were harvested from sacrificed animals and opened,
and residual food was removed. Opened stomachs were
suspended in 500 mL PBS and homogenised using 5 mm stainless
steel beads for 25 seconds at setting of 30 (Qiagen Tissue Lyser).
Samples were then homogenised for a further 2 min at a setting
of 10 to facilitate bacterial release from the tissue. Serial dilutions
of homogenates were plated on BHI based agar plates
supplemented amphotericin B (8 mg/mL), trimethoprim (5 mg/
mL) and vancomycin (6 mg/mL), nalidixic acid (10 mg/mL),
polymyxin B (10 mg/mL) and bacitracin (200 mg/mL) (24) and
Figure 4. Insertion mutant ureases are stable during persistent
infection. Western Blot analysis of H. pylori cultured from mice after 10
months colonisation, probed with anti-FLAG antibody. Where de-
scribed, each lane represents protein extracted from a pool of bacteria
harvested from an individual mouse. a) lanes 1–3: pools of X47 (wt)
from individual mouse; lane 4: molecular size marker (MW: KDa shown);
lane 5: X47 (site 1); lane 6: X47 (site 4); lane 7: X47 (site 8). b) lanes 1–5:
pools of X47 (site 1) from individual mouse; lane 7: molecular size
marker; lane 8: X47 (site 1). c) lanes 1–5: pools of X47 (site 4) from
individual mouse; lane 7: molecular size marker. d) lanes 1–3: pools of
X47 (site 8) from individual mouse; lane 5: molecular size marker; lane 6:
X47 (site 8). To confirm protein sample integrity urease activities were
assayed in wild-type X47 and in a pool of X47 insertion (site 1 mutant)
from mice in which FLAG expression was not detected (annotated *;
data not shown). Molecular of standard proteins (KDa) are shown
directly adjacent to the marker.
doi:10.1371/journal.pone.0015042.g004
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scored 5–7 days later.
SDS-PAGE and Western Blot Analysis
H. pylori were harvested from mouse stomachs, grown for 4 d,
harvested and resuspended in SDS-PAGE loading buffer.
Standard SDS-PAGE and Western Blot methodologies were
performed [30]. Electrophoresis was performed using SDS-PAGE
on a discontinuous 10% gel. For Western Blotting, proteins were
transferred to PVDF Immuno-Blot PVDF (0.2 mM) membrane
(Biorad). Membranes were blocked overnight at 2% Blocking
Reagent (Roche) in Maleic acid buffer (100 mM Maleic acid,
150 mM NaCl, pH 7.5, 20uC) supplemented with 0.2% (v/v)
Tween 20. To detect FLAG membranes were probed with a
1:1000 dilution of monoclonal anti-FLAG (Sigma Aldrich) in 1%
Blocking Reagent supplemented with 0.1% (v/v) Tween 20 for
2 hours at room temperature. For detection, membranes were
incubated with rabbit anti-mouse IgG conjugated to horse radish
Figure 5. Proposed multiple roles of Helicobacter pylori urease during infection. To explain the loss of ability to persist in strains
containing an insertion at urease surface site 8, we suggest a model of immune modulation mediated by the urease interaction with host tissue CD74
receptor. This could lead to a reduction of the pro-inflammatory response elicited by the epithelial cells or to an increase in the Th1 bias via the
dendritic cells (red boxes). Other non-enzymatic functions of urease that might contribute to persistence include facilitation of resistance to
complement mediated opsonisation [9], decreased uptake of H. pylori cells by granulocytes [8], increased H. pylori survival in macrophages [6,7], and
increased release of nutrients via compromised tight junctions [12] and/or apoptosis of epithelial cells [32].
doi:10.1371/journal.pone.0015042.g005
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identical conditions for 1 h at room temperature. Detection was
performed using Chemiluminescent Peroxidase Substrate-3 (Sig-
ma-Aldrich) and the FujiFilm LAS-3000 Imager. Urease was
similarly probed using a 1:200 dilution anti-urease alpha subunit
(bc-14; Santa Cruz Biotechnology) and detected using a 1:2500
dilution of rabbit anti-goat HRP conjugate antibody (Jackson
ImmunoResearch Laboratories, Inc.).
Enzyme-Linked ImmunoSorbent Assay (ELISA)
Mice sera were collected at different time points and assessed for
the presence of urease specific IgG. Nunc 96 well maxisorb plates
were coated with 10 ug/mL of Urease B protein (expressed from
plasmid pILL927 and purified as described in reference [31]) in
100 mL carbonate buffer and incubated overnight at 4uC. Plates
were washed 5 x with PBS supplemented with 0.05% (v/v) Tween
20 (PBST) and then blocked with 200 uL of PBS supplemented
with 2% BSA (w/v) for 2 hours at 37uC. Following 2 x washes
with PBST a 1:20 dilution mouse sera in 100 uL of PBST
supplemented with 2% (w/v) BSA was added to duplicate wells
and the plates incubated for 1 hour at room temperature.
Subsequently, plates were washed 5x with PBST and then a
1:1000 dilution of anti-mouse IgG alkaline phosphatase (Sigma
Aldrich) in 100 uL PBST supplemented with 2% (w/v) was added
to each well and the plates incubated at room temperature for
1 hour. After 5x washes with PBST, 200 uL of nitrophenyl
phosphate substrate in diethanolamine buffer was added to each
well and the plates incubated for 40 min at room temperature in
the dark before absorbance was measured at 405 nm.
Urease Stability and Activity
H. pylori were harvested after growth for 24 h on BHI base agar
plates and were rinsed in cold saline (0.9% v/v). The bacterial
suspension was diluted to an OD600 of 4 and 15 mL was added to
15 mL of saline supplemented with Tween 20 (0.2% v/v). To each
sample 90 mL of KCl (200 mM; pH 3) was added and samples
were incubated for 10 min while shaking at 300 rpm at room
temperature. Subsequently the solution was neutralised by the
addition of 120 mL of PBS (pH 6.8). 150 mL of each sample was
added to 25 mL of phenol red sodium salt (80 mg/mL) and
warmed to 37uC. The reaction was initiated by the addition of
75 mL of 0.5 M urea and the change in pH was measured by
reading absorbance at 560 nm every 70 s.
Supporting Information
Figure S1 Alignment showing conservation of ureases at
region of site 8. Alignment of H. pylori UreB (sp|P69996) at the
region of site 8, for which the crystal structure has been
determined (PDBe Entry: 1e9y), and ureases from different
species. UniProtKB/Swiss-Prot numbers are displayed.
(TIF)
Table S1 Sequences of oligonucleotides used in this
study.
(DOC)
Table S2 Primer combinations used to produce modi-
fied DNA. Primers amplified either segments of regions coding
exogenous DNA (to be inserted into urease genes) or regions used
for homologous recombination after transformation (left flank and
right flank).
(DOC)
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